Atherogenic Dyslipidemias: Unmet Needs and the Therapeutic Potential of Emerging and Novel Approaches and Drugs

Innovative lipid-modifying agents are valuable resources to improve the control of atherogenic dyslipidemias and reduce the lipid-related residual cardiovascular risk of patients with intolerance or who are not fully responsive to a consolidated standard of care (statins plus ezetimibe). Moreover, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Romandini, Alessandra, Baldassarre, Damiano, Genovese, Stefano, Capri, Stefano, Pompilio, Giulio, Scatigna, Marco, Werba, José Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963828/
https://www.ncbi.nlm.nih.gov/pubmed/37259324
http://dx.doi.org/10.3390/ph16020176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963828/
https://www.ncbi.nlm.nih.gov/pubmed/37259324
http://dx.doi.org/10.3390/ph16020176

Ejemplares similares